Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Raltitrexed,"Colorectal cancer, intolerant or contraindicated to fluoropyrimidine due to cardiac toxicity",Raltitrexed (Tomudex),Options for investment,Hospital,Oncology Agents and Immunosuppressants
